EW News and Press, Edwards Lifesciences Corporation From 12/08/21

Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference PR Newswire IRVINE, Calif. , Dec. 8, 2021 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its ...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Wells Fargo has upgraded Edwards Lifesciences (NYSE:EW) to overweight citing growth in transcatheter aortic valve replacements (TAVRs). The firm has a $126 price target (~13% upside). Analyst Larry Biegelsen expects pivotal trial data that will be presented next year on the Pascal transc...

Credit Suisse drops its best of the best picks to seven stocks for December. Credit Suisse Product Manager Andrew St. Pierre defines the "Top of the Crop" stocks as the "highest conviction combined with the least demanding market expectations. And four new names make that list. The "Top of th...

My new portfolio has already seen most companies release earnings, and results look promising. Therefore, I will cover the first thirteen companies in this article, and then the last twelve after all reports have been filed. I will be quite brief with my summaries, but I will cove...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Edwards Announces Six-month Data From Transcatheter Tricuspid Replacement Program PR Newswire IRVINE, Calif. , Nov. 6, 2021 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced that results from a clinical trial of the company's EVOQUE trans...

TAVR with SAPIEN 3 Demonstrated as Economically Dominant Treatment Strategy Compared to Surgery in Partner 3 Analysis PR Newswire IRVINE, Calif. , Nov. 5, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced that a cost-effectiveness analysis...

I've had some good discussions about my policy of selling high-quality stocks if they have become extremely overvalued. Many investors prefer to hold the stocks of quality businesses that have performed well regardless of the valuation. In this article, I share data on 43 of the h...

Credit Suisse is out with a diverse list of its favorite names for November, while adding two new top outperform ideas. Credit Suisse Product Manager Andrew St. Pierre defines the "Top of the Crop" stocks as the "highest conviction combined with the least demanding market expectations." IBM (...